June 10, 2026

• Public Notifications:
  • Business Pill may be harmful due to hidden drug ingredient
  • Branch Manager for Men may be harmful due to hidden drug ingredient
• Webinar: ClinicalTrials.gov: Essentials for Academic Medical Centers
• Drug Safety Communication: FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury

June 5, 2026

• Public Notification: Pink Pussycat Brand products may be harmful due to hidden drug ingredients

This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.